US SB1214 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on April 19 2023 - 25% progression, died in chamber
Action: 2023-06-22 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 109.
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on April 19 2023 - 25% progression, died in chamber
Action: 2023-06-22 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 109.
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to set forth limitations on exclusive approval or licensure of drugs designated for rare diseases or conditions.
Title
RARE Act Retaining Access and Restoring Exclusivity Act
Sponsors
| Sen. Tammy Baldwin [D-WI] | Sen. Mike Braun [R-IN] |
History
| Date | Chamber | Action |
|---|---|---|
| 2023-06-22 | Senate | Placed on Senate Legislative Calendar under General Orders. Calendar No. 109. |
| 2023-06-22 | Senate | Committee on Health, Education, Labor, and Pensions. Reported by Senator Sanders without amendment. Without written report. |
| 2023-05-11 | Senate | Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably. |
| 2023-04-19 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB7383 (Related) 2024-02-16 - Referred to the Subcommittee on Health.
HB3433 (Related) 2024-09-24 - Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
HB3433 (Related) 2024-09-24 - Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
